Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid
These data indicates that PVAC is a potential candidate for the treatment of ALI/ARDS induced by aspiration of gastric acid or for the control of "asthma-like" symptoms in patients with gastroesophageal reflux.
Authors
- Caijuan Dong
- Mikael Adner (ORCID: https://orcid.org/0000-0003-1634-4759)
- Jielu Liu (ORCID: https://orcid.org/0000-0003-0850-8258)
- Jonathan M. Coquet (ORCID: https://orcid.org/0000-0002-5967-4857)
- Ben Murrell (ORCID: https://orcid.org/0000-0002-0393-4445)
- Thomas Engstrand (ORCID: https://orcid.org/0000-0002-7487-6457)
- Tim Melander Bowden (ORCID: https://orcid.org/0000-0003-0851-4316)
- Alessandro Quaranta (ORCID: https://orcid.org/0000-0002-3167-3772)
- Craig E. Wheelock (ORCID: https://orcid.org/0000-0002-8113-0653)
- Jing Xu (ORCID: https://orcid.org/0000-0003-0070-0907)
- Mu Nie (ORCID: https://orcid.org/0009-0000-9429-5783)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3389/fphar.2024.1503648
- Citations
- 2
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Hjärt-Lungfonden
- Karolinska Institutet
- Vetenskapsrådet
- China Scholarship Council